DVHGF (Devonian Health Group) Other Long-Term Liabilities: $-0.00 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DVHGF Devonian Health Group Inc DVHGF
35 GF Score
Price $7.00
! 7 Warning Signs
View Full Analysis

What is Devonian Health Group Other Long-Term Liabilities?

Devonian Health Group DVHGF 35 Other Long-Term Liabilities is $-0.00 Mil as of Apr. 2026. GuruFocus rates DVHGF with a GF Score™ of 35/100. The stock has 7 warning signs investors should review.

Devonian Health Group's other long-term liabilities for the quarter that ended in Apr. 2026 was $-0.00 Mil.

Devonian Health Group's quarterly other long-term liabilities increased from Oct. 2025 ($-0.00 Mil) to Jan. 2026 ($0.00 Mil) but then declined from Jan. 2026 ($0.00 Mil) to Apr. 2026 ($-0.00 Mil).

Devonian Health Group's annual other long-term liabilities declined from Jul. 2023 ($0.00 Mil) to Jul. 2024 ($-0.00 Mil) but then increased from Jul. 2024 ($-0.00 Mil) to Jul. 2025 ($0.00 Mil).

Devonian Health Group Other Long-Term Liabilities Related Terms

Devonian Health Group Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Devonian Health Group's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Devonian Health Group Other Long-Term Liabilities Chart

Devonian Health Group Annual Data
Trend Jun16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 0.00 -0.00 0.00

Devonian Health Group Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 0.00 -0.00
DVHGF
35GF Score
Devonian Health Group Inc DVHGF
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Devonian Health Group Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $-0.00 Mil mean?
Devonian Health Group (DVHGF) has a Other Long-Term Liabilities of $-0.00 Mil as of Apr. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Devonian Health Group and its competitors.
Is Devonian Health Group's Other Long-Term Liabilities too high?
Devonian Health Group's current Other Long-Term Liabilities is $-0.00 Mil. Overall, Devonian Health Group has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Devonian Health Group's Other Long-Term Liabilities compare to VRTX and REGN?
Devonian Health Group's Other Long-Term Liabilities of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Biotechnology company?
A good Other Long-Term Liabilities depends on the Biotechnology industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Devonian Health Group and its competitors. Devonian Health Group's current Other Long-Term Liabilities is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devonian Health Group stock overvalued right now?
Devonian Health Group (DVHGF) has a current Other Long-Term Liabilities of $-0.00 Mil. The current Other Long-Term Liabilities is $-0.00 Mil. Devonian Health Group's overall GF Score™ is 35/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Devonian Health Group (DVHGF), the current Other Long-Term Liabilities is $-0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Devonian Health Group Business Description

Other Exchanges GSD:Canada
Address 360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.
35GF Score

Get the complete analysis for DVHGF

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.00
Price